BridgeBio Pharma, Inc.'s Attruby (Acoramidis) delivers early, durable reductions in cumulative cardiovascular events. Learn ...
Envista Logo (PRNewsfoto/Envista Holdings Corporation) "This was another strong quarter for Envista, with core growth, adjusted EBITDA, and adjusted EPS all ahead of expectations, ...
Hubbell Incorporated (NYSE: HUBB) today reported operating results for the third quarter ended September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback